Oxford Science Enterprises focuses on early-stage investments in transformational businesses spun out of the University of Oxford, primarily across Life Sciences, Health Tech, AI & Software, and Deep Technology sectors. Their strategy involves providing patient, long-term capital, hands-on venture building, and operational support to guide these companies from inception to global scale.
Portfolio
3
Fund Size
$1.4B
Top Stage
Series B
Last 12 Mo
1
Stage Distribution
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Scripta Therapeutics | Seed | $12M | Nov 2025 |
| BibliU | Series B | $15M | Jun 2022 |
| PQShield | Series A | $20M | Jan 2022 |
Top Co-Investors
Last updated: 27 February 2026